resveratrolFinding
Resveratrol decreases interleukin‑6 concentration
lowersVery limited evidenceFinding
01 · The sentence it was drawn from
“A significant reduction of IL-6 concentration was observed only in the patients receiving ≥500 mg/day dose of resveratrol (WMD = -1.89 pg/ml, 95% CI = -3.73 to -0.05, P = 0.04) with inter-study heterogeneity (I2 = 94.4%, P < 0.001).”
resveratrol
Interleukin- 6 concentration
lowers
Effect as reported
CI −3.73 to −0.05
- Who
- Adults with inflammatory disease receiving ≥500 mg/day resveratrol (dose subgroup, one of 26 studies on IL-6 per Methods); the abstract does not report a significant result for the overall/lower-dose population.
- Dose studied
- ≥500 mg/day (dose-stratified subgroup)
Very limited evidencePMID 34303665 · 2021
02 · The study
- Study
- meta-analysis
- Duration
- not reported
Evidence, by strength
- strong
- moderate
- limited
- very limitedthis finding
- insufficient
03 · The paper
European journal of pharmacology04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M3R2HN600AF1TNCQAQK3CW34